Elisabeth Thijssen, PhD, Chief Scientific Officer of Neurogen Biomarking.
What You Should Know:
– Advancements in accelerating early Alzheimer’s disease (AD) screening and access to care, proven from three diverse community pilot initiatives, were presented today…
Continue Reading
Traditional in-person neuropsychological tests remain inaccessible and not adapted to individuals in remote geographical locations and linguistically diverse populations. We aimed to make neuropsychological tests more accessible and adapted to diverse populations by leveraging…
Continue Reading
What You Should Know:
– Creyos, an online platform for objective cognitive and behavioral health assessments, today announced a strategic partnership with Redox, a prominent provider of healthcare data interoperability solutions.
– The collaboration is set…
Continue Reading
What You Should Know:
– Linus Health has introduced Anywhere for Health Systems™, an innovative, FDA-listed, AI-enhanced cognitive assessment designed to address the critical issue of undetected mild cognitive impairment (MCI), a precursor to dementia.
–…
Continue Reading
Groundbreaking Technology Reshapes Cognitive Care
A revolutionary advancement in dementia detection has emerged through Together Senior Health’s RADAR algorithm, with recent Milliman testing confirming its exceptional predictive capabilities. This innovative technology, now part of Linus…
